Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Clarke

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Nature Communications|September 20, 2022
DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survivalJ K Wiencke, Annette M Molinaro, Gayathri Warrier, et al.
British Journal of Haematology|December 16, 2020
Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activationSoracha E Ward, Gerard F Curley, Michelle Lavin, et al.
Msphere|March 8, 2023
Evidence for a Causal Role for Escherichia coli Strains Identified as Adherent-Invasive (AIEC) in Intestinal InflammationHatem Kittana, João C Gomes-Neto, Kari Heck, et al.
Acta Neuropathologica|March 4, 2017
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERTMelike Pekmezci, Terri Rice, Annette M Molinaro, et al.
Ebiomedicine|February 26, 2022
Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implicationsOisin F McElvaney, Takanori Asakura, Suzanne L Meinig, et al.
Med (New York, N.Y.)|March 16, 2022
A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19Oliver J McElvaney, Natalie L McEvoy, Fiona Boland, et al.
American Journal of Human Genetics|April 14, 2009
Genetic control of human brain transcript expression in Alzheimer diseaseJennifer A Webster, J Raphael Gibbs, Jennifer Clarke, et al.
Acta Neuropathologica|September 10, 2018
The genetic landscape of gliomas arising after therapeutic radiationGiselle Y López, Jessica Van Ziffle, Courtney Onodera, et al.
The New England Journal of Medicine|June 5, 2023
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade GliomaIngo K Mellinghoff, Martin J van den Bent, Deborah T Blumenthal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2023
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade GliomaShawn L Hervey-Jumper, Yalan Zhang, Joanna J Phillips, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Nature Communications|September 20, 2022
DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survivalJ K Wiencke, Annette M Molinaro, Gayathri Warrier, et al.
British Journal of Haematology|December 16, 2020
Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activationSoracha E Ward, Gerard F Curley, Michelle Lavin, et al.
Msphere|March 8, 2023
Evidence for a Causal Role for Escherichia coli Strains Identified as Adherent-Invasive (AIEC) in Intestinal InflammationHatem Kittana, João C Gomes-Neto, Kari Heck, et al.
Acta Neuropathologica|March 4, 2017
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERTMelike Pekmezci, Terri Rice, Annette M Molinaro, et al.
Ebiomedicine|February 26, 2022
Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implicationsOisin F McElvaney, Takanori Asakura, Suzanne L Meinig, et al.
Med (New York, N.Y.)|March 16, 2022
A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19Oliver J McElvaney, Natalie L McEvoy, Fiona Boland, et al.
American Journal of Human Genetics|April 14, 2009
Genetic control of human brain transcript expression in Alzheimer diseaseJennifer A Webster, J Raphael Gibbs, Jennifer Clarke, et al.
Acta Neuropathologica|September 10, 2018
The genetic landscape of gliomas arising after therapeutic radiationGiselle Y López, Jessica Van Ziffle, Courtney Onodera, et al.
The New England Journal of Medicine|June 5, 2023
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade GliomaIngo K Mellinghoff, Martin J van den Bent, Deborah T Blumenthal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2023
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade GliomaShawn L Hervey-Jumper, Yalan Zhang, Joanna J Phillips, et al.
Pageof 14